Prevalence and antimicrobial resistance pattern of bacterial strains isolated from patients with urinary tract infection in Messalata Central Hospital, Libya  by Mohammed, Mahmoud A. et al.
HOSTED BY Contents lists available at ScienceDirect
Asian Paciﬁc Journal of Tropical Medicine 2016; 9(8): 771–776 771Asian Paciﬁc Journal of Tropical Medicine
journal homepage: http://ees.elsevier.com/apjtmOriginal research http://dx.doi.org/10.1016/j.apjtm.2016.06.011*Corresponding author: Tarig M.S. Alnour, Department of Medical Laboratory
Technology, Faculty of Applied Medical Sciences, University of Tabuk, Saudi Arabia.
Tel: +966 535782141
E-mails: telnour@ut.edu.sa, tarigms@yahoo.com
Peer review under the responsibility of Hainan Medical College.
1995-7645/Copyright © 2016 Hainan Medical College. Production and hosting by Elsevier B.V. This is an open access articl
creativecommons.org/licenses/by-nc-nd/4.0/).Prevalence and antimicrobial resistance pattern of bacterial strains isolated from patients with
urinary tract infection in Messalata Central Hospital, LibyaMahmoud A. Mohammed1,2, Tarig M.S. Alnour1,3*, Osama M. Shakurfo1, Mariam M. Aburass11Department of Medical Laboratory Technology, Faculty of Medical Technologies-Messalata, Almergib University, Libya
2Department of Food Hygiene and Control, Faculty of Veterinary Medicine, Mansoura University, Mansoura 35516, Egypt
3Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, University of Tabuk, Saudi ArabiaARTICLE INFO
Article history:
Received 15 May 2016
Received in revised form 16 Jun 2016
Accepted 21 Jun 2016
Available online 28 Jun 2016
Keywords:
Urinary tract infection (UTI)
Uropathogens
Signiﬁcant bacteriuria
Antimicrobial susceptibility testing,
(AST)
Antimicrobial resistance
EnterobacteriaceaeABSTRACT
Objectives: To investigate the prevalence of urinary tract infection among patients at
Messalata Central Hospital, Libya, to identify the causative bacteria, and to explore their
resistance pattern to antimicrobials.
Methods: A total number of 1 153 urine samples were collected from patients, who
attended daily to Messalata Central Hospital, Libya, in a study extended for one year.
Antimicrobial susceptibility testing and isolates typing were done using Phoenix BD (BD
diagnostic). Resistance was conﬁrmed manually using agar disk diffusion method.
Results: Of the 1 153 urine samples tested, 160 (13.9%) samples were positive, from
which 17 different, solely Gram negative, uropathogens were identiﬁed. Escherichia coli
were the most prevalent (55.6%) bacteria, followed by Klebsiella pneumoniae subspecies
pneumoniae (16.3%), Proteus mirabilis (6.3%), Pseudomonas aeruginosa (5.6%),
Enterobacter cloacae and Klebsiella oxytoca (2.5%, each), Citrobacter koseri and
Providencia rettgeri (1.9%, each), Acinetobacter baumannii, Enterobacter aerogenes and
Proteus vulgaris (1.3%, each), and Aeromonas caviae, Citrobacter freundii, Cronobacter
sakazakii, Enterobacter amnigenus biogroup 2, Pseudomonas putida and Serratia mar-
cescens (0.6%, each). The isolated uropathogens showed increased levels of resistance
ranged from 10.5% to 64.5%, with an overall resistance of 28.9%. Amikacin was the
most effective antimicrobial followed by Imipenem and Meropenem (0%, 0.6% and 2.5%
resistance, respectively); while, Cephalothin and Ampicillin were the least (80.6% and
90.0% resistance, respectively) effective.
Conclusions: The obtained results emphasized the emergence of highly resistant bacteria
to most of tested antimicrobials and raise the alarm for physicians to change their
treatment pattern depending on antimicrobial susceptibility results.1. Introduction
Urinary tract infection (UTI) is a term applied to a variety of
clinical conditions ranging from asymptomatic occurrence of
bacteria in the urine to severe kidney infection with resultant
sepsis [1]. It is one of the most common bacterial infections
encountered by clinicians in developing countries. Worldwide,
about 150 million people are diagnosed with UTI each year,
resulting in at least 6 billion dollars in health care expenses [2].
Urinary tract infection occurs in all populations and ages,
however, various factors including race, genetic factors, age,gender, sexual activity, nocturnal enuresis and circumcision in
boys, make bacteriuria more or less to occur for any individual [3].
Moreover, infrequent micturition and incomplete emptying of the
bladder in children besides urine and fecal elimination and poor
toilet habits are consider possible causes for UTI [4].
Additionally, pregnancy in women and prostate enlargement
in men can predispose the infection; however, women, especially
sexually active, are more prone to UTIs than males. Furthermore,
UTI can be also increased due to prolonged use of antibiotics
(antimicrobials), since prolonged use of antibiotics can damage
periurethral ﬂora allowing uropathogens to colonize and infect
the urinary tract [5,6].
Urinary tract infections are mainly caused by Gram negative
bacteria which account for 80–85% and the leading causative
organisms are Escherichia coli (E. coli) (75.5–87% of UTI
cases) followed by Klebsiella species, in addition to Citrobacter,e under the CC BY-NC-ND license (http://
Table 1
Prevalence of urinary tract infection among tested patients in relation to
gender and age.
Character Number Percentage (%)
Examined patients 1 153 100.0
Infected 160 13.9
Negative 993 86.1
Gender
Female 96 60.0
Male 64 40.0
Age group
<1 8 5.0
2–5 25 15.6
6–12 23 14.4
13–18 1 0.6
19–45 56 35.0
46–60 17 10.6
>61 30 18.8
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ratia and Proteus species; however, Enterococcus and Staphy-
lococcus species are the causative Gram positive agents for the
remainder infections [7,8].
The clinical symptoms of UTIs usually include frequency,
urgency, painful urination, sensation of having to urinate after
urination, dysuria, pyuria, back pain, abdominal pain. However,
bacteria may be present in the urinary tract without any apparent
symptoms [9].
Although UTIs are commonly curable with antibiotics,
widespread use of antibiotics given empirically without proper
antibiotic susceptibility testing has inevitably led to a massive
increase in UTIs caused by drug-resistant bacteria. This has
made antibiotic choice for empirical and rational treatment very
difﬁcult [10]. The emergence of bacterial resistance problem is
increasing due to the inappropriate use of antibiotic
prophylaxis, self medication with some types of antibiotics
and the inadequate dosage of these antibiotics. So, to ensure
appropriate therapy, current knowledge of the organisms that
cause UTIs and their antibiotic susceptibility is mandatory [11].
In developing countries, like Libya, it is difﬁcult to assess the
accurate incidence of UTI besides bacterial resistance due to
underreporting, lack of surveillance as well limited published
data. Therefore, this study was designed to investigate the
prevalence of UTI among patients at Messalata Central Hospital,
Libya, to identify causative bacteria and explore their antimi-
crobial resistance patterns, which may constitute an epidemio-
logical importance regarding the wide-spread of multi-drug
resistant bacteria in this country.
2. Materials and methods
2.1. Samples collection, handling and processing
A total of 1 153 urine samples were collected from patients,
who attended daily to Messalata Central Hospital, Libya, in a
study extended for one year. The collected samples were, indi-
vidually, labeled with patient information including age, gender,
clinical symptoms and results of physical examination, then sent
to the microbiological laboratory for isolation and identiﬁcation
of any bacterial pathogen, in which samples were processed
immediately within 30 min.
The patient instruction for appropriate collection has been
followed to reduce probable contamination. In adult and toilet-
trained children, urine samples were collected, using clean-
catch midstream specimens, in wide-mouthed sterile containers
with tight-ﬁtting lid to prevent leakage. In infants, adhesive urine
collection bags were used for specimen collection.
2.2. Cultivation, isolation and identiﬁcation of
uropathogens
Collected samples were, separately, inoculated onto Blood
agar (Oxoid, UK) and MacConkey agar (Oxoid, UK), and then
plates were incubated, aerobically, at 37 C for 24 h extended to
48 h in negative samples. Colony counts of a single microor-
ganism of>105 colony forming units (cfu)/mL were diagnosed as
bacteriuria. The Phoenix BD automated identiﬁcation system (BD
Diagnostics, Baltimore, MD, USA) was used in this study, ac-
cording to the manufacturer's recommendations. The Phoenix BD
was designed for both rapid identiﬁcation (ID) (45wellswith driedbiochemical substrates and 2 ﬂuorescent control wells) and anti-
microbial susceptibility testing (AST) (up to 84 wells with dried
antimicrobial panels) of clinically important bacterial pathogens.
The Phoenix identiﬁcation method uses modiﬁed conventional,
ﬂuorogenic and chromogenic substrates as a redox indicator for
the detection of bacterial growth in the presence of an antimi-
crobial agent [12]. Brieﬂy, the ID broth was, individually,
inoculated with bacterial colonies from a pure culture adjusted
to a 0.5 to 0.6 McFarland standard using a CrystalSpec
nephelometer (BD Diagnostics). A 25 mL aliquot of this
suspension was removed for AST and the remaining suspension
was then poured into the ID side of the Phoenix panel. Valid
isolate identiﬁcation required a score greater than 90%;
otherwise, no identiﬁcation was reported. The assay is
employed in doubling antimicrobic concentrations which
measures minimum inhibitory concentrations (MIC) at 20 min
intervals during the testing of panels. Additionally,
antimicrobial susceptibility patterns were also conﬁrmed by the
agar disk diffusion standard method using Muller Hinton agar
(Oxoid, CM0337) supplemented with 5% deﬁbrinated horse
blood according to the National Committee of Clinical
Laboratory Standards (NCCLS) guidelines [13].
The tested antimicrobials in this study were Amikacin,
Gentamicin, Ertapenem, Imipenem, Meropenem, Cephalothin,
Cefuroxime, Cefoxitin, Ceftazidime, Ceftriaxone, Cefepime,
Aztreonam, Ampicillin, Amoxicillin–Clavulanate, Piperacillin–
Tazobactam, Trimethoprim–Sulfamethoxazole, Nitrofurantoin,
Ciproﬂoxacin and Levoﬂoxacin.
2.3. Statistical analysis
Statistical analyses were done by using Microsoft Ofﬁce
Excel 2007, SPSS version 12 (Statistical Package for Social
Sciences). Evaluations were carried out at 95% conﬁdence level
and P < 0.05 was considered statistically signiﬁcant.
3. Results
3.1. Prevalence of UTI in tested patients
Of the 1 153 urine samples tested, 160 (13.9%) samples were
positive for the presence of bacterial pathogens while 993
(86.1%) were negative (Table 1). Each positive sample was
Mahmoud A. Mohammed et al./Asian Paciﬁc Journal of Tropical Medicine 2016; 9(8): 771–776 773represented by one bacterial isolate. In relation to gender of
patients with UTI, 96 (60.0%) were females and 64 (40%) were
males (Table 1).
About the distribution of infection among patients' age
groups, which ranged between 19 days and 95 years, the highest
(35.0%, 56/160) occurrence was in young age adults (19–45
years), followed by elderly (>61 years), then early children (2–5
years), late children (6–12 years), late adults (46–60 years), in-
fants (<1 year), and the lowest (0.6%, 1/160) incidence was
among adolescents (13–18 years) (Table 1).
Concerning the distribution of isolated uropathogens in
relation to patients' gender, the majority (15 of 17) of bacterialTable 2
Frequency distribution of isolated uropathogens among patients' gender
[n (%)].
Isolated uropathogens Total Female Male
Acinetobacter baumannii 2 (1.3) 2 (100.0) –
Aeromonas caviae 1 (0.6) 1 (100.0) –
Citrobacter freundii 1 (0.6) 1 (100.0) –
Citrobacter koseri 3 (1.9) 1 (33.3) 2 (66.7)
Cronobacter sakazakii 1 (0.6) 1 (100.0) –
Enterobacter aerogenes 2 (1.3) 1 (50.0) 1 (50.0)
Enterobacter amnigenus
biogroup 2
1 (0.6) – 1 (100.0)
Enterobacter cloacae 4 (2.5) 3 (75.0) 1 (25.0)
Escherichia coli 89 (55.6) 59 (66.3) 30 (33.7)
Klebsiella oxytoca 4 (2.5) 3 (75.0) 1 (25.0)
Klebsiella pneumoniae
subspecies pneumoniae
26 (16.3) 13 (50.0) 13 (50.0)
Proteus mirabilis 10 (6.3) 4 (40.0) 6 (60.0)
Proteus vulgaris 2 (1.3) 1 (50.0) 1 (50.0)
Providencia rettgeri 3 (1.9) 1 (33.3) 2 (66.7)
Pseudomonas aeruginosa 9 (5.6) 4 (44.4) 5 (55.6)
Pseudomonas putida 1 (0.6) – 1 (100.0)
Serratia marcescens 1 (0.6) 1 (100.0) –
Total 160 (100.0) 96 (60.0) 64 (40.0)
Table 3a
Distribution of resistance of isolated uropathogens to tested antimicrobials.
Tested
antimicrobials
Acinetobacter
baumannii
Aeromonas
caviae
Citrobacter
freundii
Citrobacter
koseri
Amikacin 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Gentamicin 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Ertapenem 2 (100.0) 1 (100.0) 1 (100) 0 (0.0)
Imipenem 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Meropenem 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Cephalothin 2 (100.0) 1 (100.0) 1 (100.0) 1 (33.3)
Cefuroxime 2 (100.0) 1 (100.0) 1 (100) 1 (33.3)
Cefoxitin 2 (100.0) 1 (100.0) 1 (100) 0 (0.0)
Ceftazidime 1 (50.0) 0 (0.0) 0 (0.0) 0 (0.0)
Ceftriaxone 0 (0.0) 0 (0.0) 1 (100.0) 0 (0.0)
Cefepime 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Aztreonam 2 (100.0) 0 (0.0) 0 (0.0) 0 (0.0)
Ampicillin 2 (100.0) 1 (100.0) 1 (100.0) 3 (100.0)
Amoxicillin–
Clavulanate
2 (100.0) 0 (0.0) 1 (100.0) 0 (0.0)
Piperacillin–
Tazobactam
0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Trimethoprim–
Sulfamethoxazole
1 (50.0) 0 (0.0) 1 (100.0) 0 (0.0)
Nitrofurantoin 2 (100.0) NA* 1 (100.0) 1 (33.3)
Ciproﬂoxacin 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Levoﬂoxacin 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Total 18 (47.4) 5 (27.8) 9 (47.4) 6 (10.5)
Distribution of resistance of isolated uropathogens to tested antimicrobials.species were isolated from female patients; however, only 12
bacterial species were isolated from male patients (Table 2). The
order of prevalence of uropathogens isolated from female pa-
tients was Acinetobacter baumannii (A. baumannii), Aeromonas
caviae (A. caviae), Citrobacter freundii (C. freundii), Crono-
bacter sakazakii (C. sakazakii) and Serratia marcescens
(100.0%, each) followed by Enterobacter cloacae (E. cloacae)
and Klebsiella oxytoca (K. oxytoca) (75.0%, each), E. coli
(66.3%), Enterobacter aerogenes (E. aerogenes), Klebsiella
pneumoniae subspecies pneumoniae (K. pneumoniae subspecies
pneumoniae) and Proteus vulgaris (50.0%, each), Pseudomonas
aeruginosa (P. aeruginosa) (44.4%), Proteus mirabilis
(P. mirabilis) (40.0%) and Citrobacter koseri (C. koseri), and
Providencia rettgeri (P. rettgeri) (33.3%, each); but this order in
male patients was Enterobacter amnigenus biogroup 2 and
Pseudomonas putida (100.0%, each), C. koseri and P. rettgeri
(66.7%, each), P. mirabilis (60.0%), P. aeruginosa (55.6%),
E. aerogenes, K. pneumoniae subspecies pneumoniae and
P. vulgaris (50.0%, each), E. coli (33.7%), and E. cloacae and
K. oxytoca (25.0%, each) (Table 2).
3.2. Frequency of resistance among isolated
uropathogens to tested antimicrobials
In this study, all isolated bacteria, except C. koseri and
C. sakazakii, showed increased resistance to wide range of used
antimicrobials including recently produced and expensive ones.
Our results established that isolated K. pneumoniae subspecies
pneumoniae, E. coli, K. oxytoca, P. rettgeri and P. aeruginosa
were highly (33.0%, 22.4%, 64.5%, 63.2% and 52.1%, respec-
tively) resistant and exhibit resistance to all tested antimicrobials
except Amikacin and Imipenem; Amikacin, Imipenem and
Meropenem; Amikacin, Gentamicin, Imipenem and Mer-
openem; Amikacin, Imipenem, Meropenem and Piperacillin–
Tazobactam; Amikacin, Gentamicin, Cefepime and Piperacillin–Cronobacter
sakazakii
Enterobacter
aerogenes
Enterobacter
amnigenus
Enterobacter
cloacae
Escherichia
coli
0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 11 (12.4)
0 (0.0) 1 (50.0) 0 (0.0) 1 (25.0) 8 (9)
0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
0 (0.0) 2 (100.0) 1 (100.0) 4 (100.0) 78 (87.6)
0 (0.0) 2 (100.0) 0 (0.0) 4 (100.0) 18 (20.2)
0 (0.0) 2 (100.0) 1 (100.0) 4 (100.0) 8 (9.0)
0 (0.0) 0 (0.0) 0 (0.0) 1 (25.0) 9 (10.1)
0 (0.0) 1 (50.0) 0 (0.0) 2 (50.0) 16 (18)
0 (0.0) 1 (50.0) 0 (0.0) 2 (50.0) 17 (19.1)
0 (0.0) 0 (0.0) 0 (0.0) 1 (25) 11 (12.4)
1 (100.0) 2 (100.0) 1 (100.0) 4 (100.0) 76 (85.4)
0 (0.0) 2 (100.0) 1 (100.0) 4 (100.0) 36 (40.4)
0 (0.0) 0 (0.0) 0 (0.0) 1 (25.0) 7 (7.9)
0 (0.0) 2 (100.0) 1 (100.0) 0 (0.0) 26 (29.2)
1 (100.0) 1 (50.0) 1 (100.0) 3 (75.0) 11 (12.4)
0 (0.0) 1 (50.0) 1 (100.0) 0 (0.0) 23 (25.8)
0 (0.0) 1 (50.0) 1 (100.0) 0 (0.0) 23 (25.8)
2 (10.5) 18 (47.4) 8 (42.1) 31 (40.8) 378 (22.4)
*N/A: not applied.
Table 3b
Distribution of resistance of isolated uropathogens to tested antimicrobials.
Tested
antimicrobials
Klebsiella
oxytoca
Klebsiella pneumoniae
subspecies
pneumoniae
Proteus
mirabilis
Proteus
vulgaris
Providencia
rettgeri
Pseudomonas
aeruginosa
Pseudomonas
putida
Serratia
marcescens
Total
bacterial
resistance
Amikacin 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Gentamicin 0 (0.0) 6 (23.1) 2 (20.0) 0 (0.0) 1 (33.3) 0 (0.0) 0 (0.0) 0 (0.0) 20 (12.5)
Ertapenem 2 (50.0) 7 (26.9) 2 (20.0) 0 (0.0) 3 (100.0) 8 (88.9) 0 (0.0) 0 (0.0) 36 (22.5)
Imipenem 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (11.1) 0 (0.0) 0 (0.0) 1 (0.6)
Meropenem 0 (0.0) 2 (7.7) 0 (0.0) 0 (0.0) 0 (0.0) 2 (22.2) 0 (0.0) 0 (0.0) 4 (2.5)
Cephalothin 4 (100.0) 15 (57.7) 4 (40.0) 2 (100.0) 3 (100.0) 9 (100.0) 1 (100.0) 1 (100.0) 129 (80.6)
Cefuroxime 4 (100.0) 12 (46.2) 3 (30.0) 2 (100.0) 3 (100.0) 9 (100.0) 1 (100.0) 1 (100.0) 64 (40.0)
Cefoxitin 4 (100.0) 5 (19.2) 0 (0.0) 0 (0.0) 2 (66.7) 9 (100.0) 1 (100.0) 1 (100.0) 41 (25.6)
Ceftazidime 1 (25.0) 9 (34.6) 0 (0.0) 0 (0.0) 1 (33.3) 1 (11.1) 0 (0.0) 0 (0.0) 23 (14.4)
Ceftriaxone 4 (100.0) 10 (38.5) 2 (20.0) 2 (100.0) 3 (100.0) 9 (100.0) 1 (100.0) 0 (0.0) 51 (31.9)
Cefepime 4 (100.0) 10 (38.5) 0 (0.0) 0 (0.0) 1 (33.3) 0 (0.0) 0 (0.0) 0 (0.0) 35 (21.9)
Aztreonam 4 (100.0) 10 (38.5) 0 (0.0) 0 (0.0) 1 (33.3) 3 (33.3) 0 (0.0) 0 (0.0) 32 (20.0)
Ampicillin 4 (100.0) 26 (100.0) 7 (70.0) 2 (100.0) 3 (100.0) 9 (100.0) 1 (100.0) 1 (100.0) 144 (90.0)
Amoxicillin–
Clavulanate
4 (100.0) 10 (38.5) 2 (20.0) 0 (0.0) 3 (100.0) 9 (100.0) 1 (100.0) 1 (100.0) 76 (47.5)
Piperacillin–
Tazobactam
4 (100.0) 6 (23.1) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 18 (11.3)
Trimethoprim–
Sulfamethoxazole
2 (50.0) 7 (26.9) 3 (30.0) 0 (0.0) 3 (100.0) 9 (100.0) 0 (0.0) 0 (0.0) 55 (34.4)
Nitrofurantoin 4 (100.0) 14 (53.8) 10 (100.0) 2 (100.0) 3 (100.0) 9 (100.0) 1 (100.0) 1 (100.0) 65 (40.9)
Ciproﬂoxacin 2 (50.0) 8 (30.8) 4 (40.0) 1 (50.0) 3 (100.0) 1 (11.1) 0 (0.0) 0 (0.0) 44 (27.5)
Levoﬂoxacin 2 (50.0) 6 (23.1) 3 (30.0) 1 (50.0) 3 (100.0) 1 (11.1) 0 (0.0) 0 (0.0) 41 (25.6)
Total 49 (64.5) 163 (33.0) 42 (22.1) 12 (31.6) 36 (63.2) 89 (52.1) 7 (36.8) 6 (31.6) 879 (28.9)
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isolated from urine sample of 3 years old female, was sensitive
to all tested antimicrobials except Ampicillin and Nitrofurantoin.
Considering our results, Amikacin was the most (0% resistance)
powerful antimicrobial followed by Imipenem (0.6% resistance)
and Meropenem (2.5% resistance) which affected 100.0%,
99.4% and 97.5% of tested uropathogens, respectively; on the
other hand, Cephalothin and Ampicillin were the least (80.6% &
90.0% resistance, respectively) effective ones and affected only
19.4% and 10.0% of tested isolates, respectively. The effect
(resistance% & sensitivity%) of remaining antimicrobials were
ordered as follow; Piperacillin–Tazobactam (11.3% & 88.7%),
Gentamicin (12.5% & 87.5%), Ceftazidime (14.4% & 85.6%),
Aztreonam (20.0% & 80.0%), Cefepime (21.9% & 78.1%),
Ertapenem (22.5% & 77.5%), Cefoxitin and Levoﬂoxacin
(25.6% & 74.4%, each), Ciproﬂoxacin (27.5% & 72.5%), Cef-
triaxone (31.9% & 68.1%), Trimethoprim–Sulfamethoxazole
(34.4% & 65.6%), Cefuroxime (40.0% & 60.0%), Nitro-
furantoin (40.9% & 59.1%), Amoxicillin–Clavulanate (47.5% &
52.5%), Meropenem (2.5% & 97.5%), Imipenem (0.6% &
99.4%) and Amikacin (0.0% &100.0%).
The isolated uropathogens showed increased resistances
ranged from 10.5% to 64.5%, with an overall resistance of
28.9%. K. oxytoca and P. rettgeri were the most resistant (64.5%
& 63.2%, respectively) species, while C. koseri and C. sakazakii
were the lowest (10.5%, each) resistant organisms. The
remaining bacterial species showed resistance in the following
order, P. aeruginosa (52.1%), A. baumannii, C. freundii and
E. aerogenes (47.4%, each), Enterobacter amnigenus biogroup
2 (42.1%), E. cloacae (40.8%), Pseudomonas putida (36.8%),
K. pneumoniae subspecies pneumoniae (33%), P. vulgaris and
S. marcescens (31.6%, each), A. caviae (27.8%), E. coli
(22.4%), and P. mirabilis (22.1%) (Tables 3a and b).4. Discussion
This study aimed to determine the bacterial causative agent of
urinary tract infection among different groups in Messalata
central hospital. Bacterial pathogens were isolated from 13.9%
of the requested urine culture. This result nearly similar to that
previously reported [14] however, this rate of prevalence is lower
than that previously (20.7%) documented in a recent study
conducted at Zawiya city, Libya and 440/1 110 (39.6%) [15,16],
but it is higher than that previously reported [17]. The
prevalence of UTI in this study was considerably low due to
peoples' traditions who feel ashamed of going for medical
checkups, self-medications, in addition to widespread private
clinics for which most of patients especially with clinical
symptoms prefer to investigate themselves.
In relation to gender of patients majority of them were female
96 (60%). This result is correlates with previously reported by
many other researchers [18,19]. This result was expected, as
women are more prone to UTI than males because their
urethra is much shorter and closer to the anus than in males,
hence bacteria from the anus can pass easily into the urinary
tract.
Regarding the causative uropathogens in this study, all of the
isolates were belonged to Gram negative bacteria. E. coli were
the most prevalent and K. pneumoniae subspecies pneumoniae
were the second most. This ﬁnding was in agreement with the
common knowledge about the causative agents of UTI such as
that reported by Abunja et al. [15].
About the distribution of infection among patients' age
groups, an evident of higher incidence of UTI was seen in adults,
especially sexually actives, followed by elderly then among
children. In contrast to the published data, UTIs among elderly,
adults and children were 58.7%, 36.2%, and 5.1%, respectively
Mahmoud A. Mohammed et al./Asian Paciﬁc Journal of Tropical Medicine 2016; 9(8): 771–776 775[20]. While, UTI was found in 16.55% of elderly women [21], in
24.48% of old age (61–70 years) males [22]. The similarities and
differences in the type and distribution of uropathogens show a
discrepancy from country to another due to many factors as
environmental conditions, health practices, patient conditions,
personal hygiene, number of patients examined, and laboratory
procedures. Moreover, the possible causes of the higher
incidence of UTI in elderly may be attributed to many factors
including urinary tract anomalies, urinary and fecal
incontinence, decline in the immune system, malnutrition,
functional disability, diabetes, prostate enlargement in males
and post-menopausal hormonal changes in females [21,23,24].
Majority of bacterial species were isolated from female patients
while only 12 bacterial species, other thanA. baumannii,A. caviae,
C. freundii, C. sakazakii and S. marcescens, were isolated from
male patients. Our results were in agreement with other studies
which dictated that uropathogens are always predictable andE. coli
are the leading causes, besides other common Gram negative or-
ganisms as Klebsiella, Enterobacter, Proteus and Citrobacter
species [25]. All isolated bacteria in this study belonged to
Enterobacteriaceae that can live in the digestive tract, rectum,
vagina or around the urethra, from which infection occurs when
these bacteria enter the normally sterile urinary system and
multiply there [26]. Similarly, Enterobacteriaceae is the
predominant (78.7%) isolates, of which E. coli was the most
(64.0%) common organisms followed by Klebsiella species
(17.9%) [8]. K. pneumoniae, P. aeruginosa, A. baumannii and
Proteus species are very often isolated in hospitals [7].
Although, isolated uropathogens, in this study, were highly
sensitive to Amikacin, Imipenem and Meropenem, the isolates
exhibited extreme resistance to both Ampicillin and Cephalo-
thin. Also, unexpected higher resistance was detected against
Amoxicillin–Clavulanate and Nitrofurantoin followed by
Trimethoprim–Sulfamethoxazole, Ceftriaxone, Ciproﬂoxacin
and Levoﬂoxacin, which are commonly used as empirical
treatment in most of UTIs. Our results of antimicrobial resis-
tance proﬁle are consistent with many previously reported
studies [15,27,28] which declared that Amikacin, Imipenem and
Meropenem were highly effective against Gram negative
bacteria which are highly resistance to Cephalosporins (ﬁrst,
second and somewhat third generations) and Penicillins, hence
physicians advised to stop prescribing these agents as an
empiric treatment for UTIs. Additionally, majority of Gram-
negative bacteria isolated were sensitive to Gentamicin, Cefta-
zidime and Ciproﬂoxacin; however, most of these bacteria were
resistant to Ampicillin, Chloramphenicol and Amoxycillin.
Moreover, the most effective antimicrobial agent reported
was Amikacin and the least effective one was Ampicillin,
whereas Ciproﬂoxacin, Cefoxitin, Levoﬂoxacin, Nitrofurantoin,
Nalidixic acid, Chloramphenicol, Amoxycillin and Gentamicin
were effective at different levels. In a study investigated UTI
during pregnancy at Al-khoms, Libya, E. coli, Proteus species
and Klebsiella species. were highly sensitive to Nitrofurantoin,
Oﬂoxacin, Cefotaxime, Ciproﬂoxacin, Norﬂoxacin and Amika-
cin; however, higher degree of resistance was observed against
Ampicillin and Cotrimoxazole. Additionally, P. aeruginosa
isolates were resistant to all tested antimicrobials except Ami-
kacin and Nitrofurantoin [29].
The alarming ﬁnding in this study is the increased resistance
of isolated uropathogens to most of commonly used antimicro-
bials including third- and fourth-generation Cephalosporins;
Penicillins and Fluoroquinolones. The explanation behind thissituation is that these drugs are in use for a long period. More-
over, in developing countries like Libya, the massive- and mis-
use of these antimicrobials, besides they are also purchased
directly from the pharmacies without doctors' prescription as self
medication is a common practice and ﬁnally the initial use of
antimicrobial before the laboratories results of antimicrobial
susceptibility. So restrictions should be put on antibiotic
prescribing.
In conclusion, our study dictated the prevalence of UTI
among tested patients. Additionally, large numbers of bacterial
species, with E. coli are predominant, were isolated from pa-
tients especially females, which showed increased levels of
resistance to most of tested antimicrobials. In view of our study
ﬁndings we recommend Amikacin, Gentamicin, Imipenem and
Meropenem as drug of choice, with restriction to some of their
adverse effects, in treatment of urinary tract infections on the
basis of its demonstrated high sensitivity. Moreover, further
studies including different hospitals and private clinics are
imperative to highlight the emergence of multi-drug resistance
among clinical bacterial species.
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